topicSaffron Cognition Meta-Analysis
claimResults We found significant improvements mainly after administration of Ginkgo biloba, Crocus sativus, Salvia officinalis, and Melissa officinalis .It should be emphasized that some herbs and herbal formulations demonstrated efficacy comparable to that of donepezil, a widely used and approved medication, suggesting potential for phytopharmaceutical therapies as complementary approaches.
evidence level1
citationKaczmarek-Kryszak KA (2026)
sourceA comprehensive systematic review of human trials investigating herbal treatments for Alzheimer's disease and dementia.
topicSaffron Cognition Meta-Analysis
claimConclusion In light of the evidence, phytopharmaceuticals have a promising role as a co-therapeutic option or alternative for patients with dementia who do not tolerate or have contraindications to standard medications.
evidence level1
citationKaczmarek-Kryszak KA (2026)
sourceA comprehensive systematic review of human trials investigating herbal treatments for Alzheimer's disease and dementia.
topicSaffron Cognition Meta-Analysis
claimCertain phytopharmaceuticals demonstrated comparable short-term symptomatic effects to standard treatments in small trials; however, evidence is insufficient to support equivalence or superiority.
evidence level1
citationKaczmarek-Kryszak KA (2026)
sourceA comprehensive systematic review of human trials investigating herbal treatments for Alzheimer's disease and dementia.
topicSaffron Cognition Meta-Analysis
claimObjective Dementia is a group of symptoms, characterized by a loss of cognition that interferes with everyday tasks, difficulty focusing, planning, problem solving, and behavioral changes, such as apathy, anxiety, or depression.
evidence level1
citationKaczmarek-Kryszak KA (2026)
sourceA comprehensive systematic review of human trials investigating herbal treatments for Alzheimer's disease and dementia.
topicSaffron Cognition Meta-Analysis
claimLevodopa remains the most effective therapy; however, it is associated with a wide range of side effects and shows little to no efficacy against non-motor symptoms.
evidence level4
citationGalla R (2026)
sourceNeuroprotective Effects of the Combination of Green Tea, Saffron, Docosahexaenoic Acid, and α-Lipoic Acid in an In Vitro Model of Parkinson's Disease.
topicSaffron Cognition Meta-Analysis
claimThe results demonstrated that the combined treatment (Mix) significantly restored cell viability after 6-OHDA exposure and more effectively reduced oxidative and nitrosative stress, as well as lipid peroxidation, compared to single compounds.
evidence level4
citationGalla R (2026)
sourceNeuroprotective Effects of the Combination of Green Tea, Saffron, Docosahexaenoic Acid, and α-Lipoic Acid in an In Vitro Model of Parkinson's Disease.
topicSaffron Cognition Meta-Analysis
claimIn conclusion, these results indicate that the Mix has a suggest a synergistic-like impact on various disease-causing pathways in PD, highlighting its promise as a multi-faceted neuroprotective approach.
evidence level4
citationGalla R (2026)
sourceNeuroprotective Effects of the Combination of Green Tea, Saffron, Docosahexaenoic Acid, and α-Lipoic Acid in an In Vitro Model of Parkinson's Disease.
topicSaffron Cognition Meta-Analysis
claimParkinson's disease (PD) is a neurodegenerative disorder characterised by dopamine deficiency and the accumulation of α-synuclein (α-syn), which aggregates into pathological inclusions known as Lewy bodies and Lewy neurites, distributed across multiple brain regions, with a particular prevalence in dopaminergic neurons.
evidence level4
citationGalla R (2026)
sourceNeuroprotective Effects of the Combination of Green Tea, Saffron, Docosahexaenoic Acid, and α-Lipoic Acid in an In Vitro Model of Parkinson's Disease.